Research Topics
| Ronald SimonSummaryAffiliation: University of Basel Country: Switzerland Publications
| Collaborators
|
Detail Information
Publications
Tissue microarraysRonald Simon
University of Basel, Institut fur Pathologie, Schonbeinstrasse 40, Basel, Switzerland
Biotechniques 36:98-105. 2004..The TMA technology is a fast, cost-effective, and statistically powerful method that will substantially facilitate translational research...
Tissue microarray (TMA) applications: implications for molecular medicineRonald Simon
Institute of Pathology, University of Basel, Schoenbeinstrasse 40, CH 4031 Basel, Switzerland
Expert Rev Mol Med 5:1-12. 2003..Thus, TMA technology will markedly accelerate the transition from basic research to clinical applications...
Tissue microarrays in cancer diagnosisRonald Simon
Institute of Pathology, Division of Molecular Pathology, University of Basel, Switzerland
Expert Rev Mol Diagn 3:421-30. 2003..Current applications and the future potential of tissue microarray technology in cancer research and diagnosis are discussed...
Close association between HER-2 amplification and overexpression in human tumors of non-breast originCoya Tapia
Institute of Pathology, University of Basel, Basel, Switzerland
Mod Pathol 20:192-8. 2007..Such tumor entities should be carefully evaluated for a possible utility of trastuzumab treatment...
TRIO amplification and abundant mRNA expression is associated with invasive tumor growth and rapid tumor cell proliferation in urinary bladder cancerMin Zheng
Institute of Pathology, University of Basel, Schoenbeinstrasse 40, CH 4031 Basel, Switzerland
Am J Pathol 165:63-9. 2004..It is concluded that TRIO up-regulation through amplification has a potential role in bladder cancer progression...
HER2 analysis in breast cancer: reduced immunoreactivity in FISH non-informative cancer biopsiesCoya Tapia
Institute of Pathology, University of Basel, Basel, Switzerland
Int J Oncol 25:1551-7. 2004..Poor tissue quality can be easily identified in FISH analyses because of a lack of hybridization signals. Inappropriate tissue handling is more dangerous in IHC because an artificial lack of staining can be regarded as 'negative' result...
Tissue microarrays for comparing molecular features with proliferation activity in breast cancerChristian Ruiz
Institute of Pathology, University Hospital Basel, 4031 Basel, Switzerland
Int J Cancer 118:2190-4. 2006..6 mm in diameter. We conclude that associations with cell proliferation can be reliably analyzed in a TMA format...
Prevalence of KIT expression in human tumorsPhilip Th Went
Institute of Pathology, University of Basel, Basel, Switzerland
J Clin Oncol 22:4514-22. 2004..CONCLUSION: The results suggest that KIT expression occurs infrequently in most tumor types and that, with the exception of GISTs, KIT gene mutations are rare in immunohistochemically KIT-positive tumors...
E2F3 amplification and overexpression is associated with invasive tumor growth and rapid tumor cell proliferation in urinary bladder cancerMartin Oeggerli
Institute of Pathology, Schoenbeinstrasse 40, CH 4031 Basel, Switzerland
Oncogene 23:5616-23. 2004..E2F3 expression appears to provide a growth advantage to tumor cells by activating cell proliferation in a subset of bladder tumors...
Tissue microarraysRonald Simon
Institute of Pathology, University Hospital, Basel, Switzerland
Methods Mol Med 97:377-89. 2004
KIT (CD117)-positive breast cancers are infrequent and lack KIT gene mutationsRonald Simon
Institute of Pathology, University of Basel, Basel, Switzerland
Clin Cancer Res 10:178-83. 2004..KIT-positive breast cancers may not reflect "KIT up-regulation" because KIT is also expressed in normal breast epithelium. The lack of KIT mutations also argues against the therapeutic efficacy of STI571 in breast cancer...
Influence of slide aging on results of translational research studies using immunohistochemistryMartina Mirlacher
Institute for Pathology, University of Basel, CH-1031 Basel, Switzerland
Mod Pathol 17:1414-20. 2004....
Tissue microarrays for miniaturized high-throughput molecular profiling of tumorsRonald Simon
Institute of Pathology, University of Basel, Schoenbeinstrasse 40, CH-4031 Basel, Switzerland
Exp Hematol 30:1365-72. 2002..Thus, TMA technology allows miniaturized high-throughput molecular epidemiologic studies. The TMA technique will markedly accelerate the transition from basic research to clinical applications...
HER-2 and TOP2A coamplification in urinary bladder cancerRonald Simon
Institute for Pathology and Urologic Clinics, University of Basel, Basel, Switzerland
Int J Cancer 107:764-72. 2003..In summary, our data suggest that HER-2 amplifications are frequently linked to alterations of the TOP2A gene in bladder cancer. The anatomy of the 17q12-q21 amplicon may be important for response to therapies targeting HER-2 or TOP2A...
Impaired expression of the cell cycle regulator BTG2 is common in clear cell renal cell carcinomaKirsten Struckmann
Institute for Pathology, University of Basel, Basel, Switzerland
Cancer Res 64:1632-8. 2004..In both experiments, BTG2 mRNA levels did not reach values observed in normal renal tissue. These data suggest that down-regulation of BTG2 is an important step in renal cancer development...
Predictive molecular pathologyGuido Sauter
University of Basel, CH-4003 Basel, Switzerland
N Engl J Med 347:1995-6. 2002
Tissue microarrays in drug discoveryGuido Sauter
Institut of Pathology, University of Basel, Schoenbeinstrasse 40, CH-4031 Basel, Switzerland
Nat Rev Drug Discov 2:962-72. 2003
Sequence analysis and high-throughput immunohistochemical profiling of KIT (CD 117) expression in uveal melanoma using tissue microarraysMona Pache
University Eye Clinic of Basel, Basel, Switzerland
Virchows Arch 443:741-4. 2003..In conclusion, human posterior uveal melanoma frequently expresses CD117 at high levels. Although KIT mutations could not be found, it appears justified to investigate the utility of imatinib mesylate in the treatment of these patients...
Prognostic relevance of MAGE-A4 tumor antigen expression in transitional cell carcinoma of the urinary bladder: a tissue microarray studyThomas Kocher
General Surgery Service, Department of Surgery, University Hospital of Basel, Hebelstrasse 20, CH 4031 Basel, Switzerland
Int J Cancer 100:702-5. 2002..0001). These data suggest that evaluation of MAGE-A4 protein expression is useful in the identification of groups of TCCs characterized by severe prognosis, thus possibly providing indications for early MAGE TAA-targeted immunotherapy...
Amplification pattern of 12q13-q15 genes (MDM2, CDK4, GLI) in urinary bladder cancerRonald Simon
Institute for Pathology and Urologic Clinics, University of Basel, Schoenbeinstrasse 40, CH 4003 Basel, Switzerland
Oncogene 21:2476-83. 2002..04) and from low to high grade (P<0.005). These data are consistent with a high level of genetic instability in invasively growing and high-grade bladder tumors...
Selective expression of a splice variant of decay-accelerating factor in c-erbB-2-positive mammary carcinoma cells showing increased transendothelial invasivenessBurkhard Brandt
Institute of Clinical Chemistry and Laboratory Medicine, University of Muenster, Germany
Biochem Biophys Res Commun 329:318-23. 2005..Due to the fact that it could thereby not be detected in normal mammary tissues, it has to be confirmed in larger studies that the DAF splice variant might be a specific tumour marker for invasive breast cancer...
Gene expression profiling of progressive papillary noninvasive carcinomas of the urinary bladderPeter J Wild
Institute of Pathology, University of Regensburg, Regensburg, Germany
Clin Cancer Res 11:4415-29. 2005..CONCLUSIONS: Gene expression profiling revealed novel genes with potential clinical utility to select patients that are more likely to develop aggressive disease...
HER2, TOP2A, CCND1, EGFR and C-MYC oncogene amplification in colorectal cancerKhawla Al-Kuraya
Department of Human Cancer Genomic Research, Research Centre at King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia
J Clin Pathol 60:768-72. 2007..Fluorescence in situ hybridisation (FISH) was used to estimate frequencies of copy number changes of known oncogenes, including HER2, TOPO2A, CCND1, EGFR and C-MYC...
Microsatellite DNA alterations of gastrointestinal stromal tumors are predictive for outcomePaulus Schurr
Department of General, Visceral, and Thoracic Surgery and Institute of Pathology, University Medical Center Hamburg Eppendorf, Hamburg, Germany
Clin Cancer Res 12:5151-7. 2006..In gastrointestinal stromal tumors (GIST), loss of heterozygosity (LOH) on chromosome 22 and its presumptive biological function has been described. The prognostic value of these and other DNA regions for patient survival remains unclear...
Frequent homogeneous HER-2 amplification in primary and metastatic adenocarcinoma of the esophagusUta Reichelt
Department of Pathology, University Medical Center Hamburg Eppendorf, University of Hamburg, Hamburg, Germany
Mod Pathol 20:120-9. 2007..The strong concordance of the HER-2 status in primary and metastatic cancers argues for a possible response of metastases from patients with HER-2-positive primary tumors to Herceptin...
The expression and action of decay-accelerating factor (CD55) in human malignancies and cancer therapyJan Henrik Mikesch
Department of Haematology Oncology, University of Muenster, Germany
Cell Oncol 28:223-32. 2006..Therefore, DAF has already become a target for therapy. In this paper we review the role of DAF in human malignancies as described in different basic, diagnostic and experimental therapeutic studies...
High-throughput tissue microarray analysis of 11q13 gene amplification (CCND1, FGF3, FGF4, EMS1) in urinary bladder cancerBoriana M Zaharieva
Department of Medical Genetics, Medical University, Zdrave 2, 1431 Sofia, Bulgaria
J Pathol 201:603-8. 2003..6% and FGF4 in 0.8%. Overall, the amplification frequency decreased with increasing genomic distance from CCND1, suggesting that, among the genes examined, CCND1 is the major target gene in the 11q13 amplicon in bladder cancer...
Marked gene transcript level alterations occur early during radical prostatectomyThorsten Schlomm
Martini Clinic, Prostate Cancer Center, University Medical Center, Hamburg Eppendorf, Germany
Eur Urol 53:333-44. 2008..However, transcript level patterns and RNA quality could rapidly change in response to ischemic and mechanical stress. Studies have shown that this occurs both perioperatively and after surgical removal of organs...
Decay-accelerating factor (CD55): a versatile acting molecule in human malignanciesJan-Henrik Mikesch
Department of Haematology-Oncology, University Hospital, , Germany
Biochim Biophys Acta 1766:42-52. 2006..Furthermore, DAF has already been included in diagnostic or therapeutic studies. Thereby, studies applying monoclonal anti-DAF antibodies and anti-DAF vaccination for a targeted therapy have been enrolled recently...
High throughput tissue microarray analysis of FHIT expression in diffuse large cell B-cell lymphoma from Saudi ArabiaKhawla Al Kuraya
Cancer Genomics, Research Centre, King Faisal Specialist Hospital and Research Centre, Riyadh, Kingdom of Saudi Arabia
Mod Pathol 19:1124-9. 2006....
Colorectal carcinoma from Saudi Arabia. Analysis of MLH-1, MSH-2 and p53 genes by immunohistochemistry and tissue microarray analysisKhawla S Al-Kuraya
Research Research Centre, King Faisal Specialist Hospital, Riyadh, Kingdom of Saudi Arabia
Saudi Med J 27:323-8. 2006..To document the incidence and role of p53 and DNA mismatch repair proteins in colorectal carcinomas, and to evaluate the relative frequency of major molecular pathways in colorectal cancers from Saudi Arabia...
The role of CXCR4 receptor expression in breast cancer: a large tissue microarray studyOmbretta Salvucci
Department of Biomedical Sciences and Biotechnology, Division of Human Anatomy, University of Brescia, Brescia, Italy
Breast Cancer Res Treat 97:275-83. 2006..Its cytoplasmic expression is associated with breast tumor progression, suggesting potential value as a diagnostic marker...
Tissue microarrays for high-throughput molecular pathologyKhawla Al Kuraya
King Faisal Hospital and Research Center, Riyadh, Saudi Arabia
Ann Saudi Med 24:169-74. 2004..Because of its beneficial economic aspects and ability to differentiate ethnic differences in tumor biology, TMA applications may become particularly important in developing countries...
Tissue microarraysRonald Simon
Department of Pathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
Methods Mol Med 114:257-68. 2005..Because all tissues are analyzed simultaneously with the same batch of reagents, TMA studies provide an unprecedented degree of standardization, speed, and cost efficiency...
High-throughput tissue microarray analysis of CMYC amplificationin urinary bladder cancerBoriana Zaharieva
Department of Medical Genetics, Medical University of Sofia, Sofia, Bulgaria
Int J Cancer 117:952-6. 2005..Patient prognosis was not affected by CMYC gene copy number changes...
High Ep-CAM expression is associated with poor prognosis in node-positive breast cancerGilbert Spizzo
Division of Haematology and Oncology, University of Innsbruck, Innsbruck, Austria
Breast Cancer Res Treat 86:207-13. 2004....
Distinct gene expression profiles: nodal versus extranodal diffuse large B-cell lymphomaZeenath Jehan
Human Cancer Genomic Research, King Fahad National Centre for Children s Cancer and Research, Riyadh, Saudi Arabia
Oncology 75:71-80. 2008..Perceived differences in outcome between extranodal and nodal DLBCL raise the possibility that these subgroups may represent different biological and clinical entities...
